Interacting Drugs |
Anagrelide vs Drotrecogin Alfa |
Security Level |
![]() |
Mechanism |
Drotrecogin Alfa: Antiplatelet Agents may enhance the adverse/toxic effect of Drotrecogin Alfa. Bleeding may occur. |
Management |
When possible, avoid use of drotrecogin within 7 days of use of any IIb/IIIa antagonists, higher dose aspirin (more than 650 mg/day), or use of other antiplatelet agents. |
Anagrelide vs Drotrecogin Alfa
Post Review about Anagrelide vs Drotrecogin Alfa Click here to cancel reply.
Other Interactions of Anagrelide
Other Interactions of Drotrecogin Alfa
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.